https://www.avient.com/investor-center/news/avient-announces-record-third-quarter-2021-results
In millions, except per share data)
In millions, except per share data)
Condensed Consolidated Balance Sheets
https://www.avient.com/idea/tough-enough-protect-power-grid
² https://www.ferc.gov/sites/default/files/2020-04/E-4_10.pdf
Boosting rPET Quality and Safety in Packaging
Boosting rPET Quality and Safety in Packaging
https://www.avient.com/sites/default/files/2022-02/Sustainability ESG Disclosures_Silicon Dioxide.pdf
Substance Safety Summary
SUBSTANCE: Silicon Dioxide
GENERAL STATEMENT
This summary is intended to provide a general overview of the chemical substance listed above.
Additional information is available through the relevant Safety Data Sheet
(SDS).
The usual precautions, occupational exposure limits for inert dusts, industrial
hygiene and occupational safety measure for handling chemicals should be observed.
https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Colorants and Formulations_Functional Additives for IVD Devices Bulletin.pdf
Mevopur™ Healthcare Colorants and Formulations
and Mevopur™ Healthcare Functional Additives
for In Vitro Diagnostic Devices
Diagnostic devices and consumables, now more
than ever, play a vital role in delivery of safe
treatements.
As part of our commitment, we publish Avient’s Mevopur™ product policy and use limitations to assist customers in their product selection.
For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative.
1.844.4AVIENT
www.avient.com
https://www.avient.com/sites/default/files/2022-02/Sustainability ESG Disclosures_Titanium Dioxide.pdf
Worker
Workers should follow the recommended safety measures contained within the
Safety Data Sheet (SDS) and on any product packaging.
Employees should be
trained in the appropriate work processes and safety equipment to limit exposure
to chemical substances.
DOCUMENT NUMBER_ SSS-002
EXPOSURE
HUMAN HEALTH SAFETY ASSESSMENT
Human Health
The substance is used in industrial settings only.
https://www.avient.com/idea/could-polyketone-be-next-generation-nylon-alternative
Get the answers to these questions by downloading our PDF Guide to Polyketone overview brochure.
Boosting rPET Quality and Safety in Packaging
Boosting rPET Quality and Safety in Packaging
https://www.avient.com/sites/default/files/2024-05/Mevopur-Surgical Gown-Case study snapshot_0520.pdf
AVIENT SOLUTION
SAFETY + COMPLIANCE
Copyright © 2024 Avient Corporation.
https://www.avient.com/products/polymer-colorants/healthcare-colorants/mevopur-healthcare-colorants-and-formulations
Slide 1: Medical textile manufacturer
https://www.avient.com/sites/default/files/2022-05/AVNT May IR Presentation w Non GAAP Recs.pdf
Avient acquired the Clariant Color business on July 1, 2020 (the “Acquisition Date”).
To provide comparable financial results, the Company references “pro forma” financial metrics, which include the business results of Clariant Color for
periods prior to the Acquisition Date.
Financials are pro forma for the acquisition of Dyneema® and potential divestiture of Distribution
Avient Specialty
Formulators
Other Specialty /
Chemical Companies
45
Source: Peer data per Bloomberg market data as of April 21, 2022
Total Enterprise Value / NTM EBITDA
With the Dyneema and Clariant
Color business acquisition and
divestment of the PP&S business,
along with the proposed sale of
our Distribution business, our
exposure is now concentrated in
less-cyclical and high-growth
markets.
https://www.avient.com/sites/default/files/2023-06/AVNT June IR Conferences w_Non GAAP Recs.pdf
W H AT W E D O : W E A R E A F O R M UL ATO R
6
CUSTOM
FORMULATION
M AY 3 , 2 0 2 3
W E B C A S T
Keeping Safety First
o Relentless focus on best-in-class safety performance as an
ACC Responsible Care® organization
Exceeding Customer Expectations
o Complementary technologies and customer relationships offer
opportunity for future revenue synergies
o Proven innovation-led commercial strategy with strong brands
and participation across the full value chain
Collaboration in Innovation
o Leveraging Dyneema®, the world’s strongest fiber™, to
accelerate growth of sustainable, ultralight and high
performance applications
People – Culture is Everything
o Talented, passionate and collaborative associates drive an
effective integration strategy
o Strong Great Places to Work® scores reflect positive
integration efforts in first year
AVI E N T P ROT EC T I VE MAT ER I A L S I N T EG R ATI O N
8
AVI ENT PROTEC TI VE MATERI ALS
K E Y I N D U S T R I E S
PERSONAL PROTECTION
Military • Law Enforcement • First
Responders • Body Armor • Helmets •
Vehicle Protection
50%
MARINE & SUSTAINABLE
INFRASTRUCTURE
Towing / Mooring • Aquaculture •
Floating Wind • Offshore Cranes
30%
CONSUMER
Consumer • Outdoor High Performance •
Safety Equipment
20%
9
Figures reflect approximate proportions of 2022 sales
Q 1 P E R F O R M A N C E
Q1 2023 PERFORMANCE VS.
Avient Specialty
Formulators
Other Specialty /
Chemical Companies
2023E(%)
37
79
89
83 81
76
73
90
82
77 76 74
70
58
22
A
vi
e
n
t
K
W
R
P
P
G
F
U
L
A
V
Y
R
P
M
F
M
C
C
E
H
X
L
A
S
H
E
C
L
H
U
N
E
M
N
S
C
L
M U LT I P L E E X PA N S I O N
Avient Specialty
Formulators
Other Specialty /
Chemical Companies
Source: Peer data per Bloomberg as of May 31, 2023
Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $36.50.
Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years.
38
EV / 2023E EBITDA
Historic Multiple
6.5
8.3
9.6
13.2 13.0 12.8
11.3
8.6
17.9
16.8
10.7
8.8 8.8 8.7
7.5
6.9
A
vi
e
n
t
(2
0
1
1
)
A
vi
e
n
t
(2
0
1
8
)
A
vi
e
n
t
(2
0
2
3
)
K
W
R
P
P
G
R
P
M
A
V
Y
F
U
L
E
C
L
H
X
L
F
M
C
S
C
L
C
E
A
S
H
E
M
N
H
U
N
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2023-03/Mevopur Healthcare Functional Additives Antistatic Application Bulletin_0.pdf
Mevopur™ Healthcare Functional Additives
Antistatic Additive
APPLICATION BULLETIN
Plastics often undergo charge build-up, which can
lead to handling problems and electrical discharges.
As part of our commitment, we publish Avient’s Mevopur™ product policy and use limitations to assist customers in their product selection.
For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative.
1.844.4AVIENT
www.avient.com